Results 11 to 20 of about 49,264 (163)

Mitral valve repair during septal myectomy in obstructive hypertrophic cardiomyopathy [PDF]

open access: yesHeart Vessels and Transplantation, 2023
Hypertrophic cardiomyopathy is a common genetic heart disease characterized predominantly by non-dilated hypertrophy of the left ventricle, in the absence of other cardiac, systemic, or metabolic diseases that can cause the observed degree of hypertrophy.
Sergei A. Budagaev   +7 more
doaj   +2 more sources

Four-Chamber Deformation Remodeling and Atrial Fibrillation After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy. [PDF]

open access: yesEchocardiography
After septal myectomy for hypertrophic obstructive cardiomyopathy, the four chambers of the heart experience unique remodeling patterns that can be visualized with speckle‐tracking strain analysis on echocardiography. This study characterizes those changes and links them to clinical outcomes such as post‐operative atrial fibrillation risk, thereby ...
Kislitsina ON   +10 more
europepmc   +3 more sources

Effects of septal myectomy on left atrial and left ventricular function in obstructive hypertrophic cardiomyopathy

open access: yesESC Heart Failure, 2023
Aims Mechanical function of the left atrium (LA) and the left ventricle (LV) has been demonstrated to be a prognostic factor in patients with hypertrophic cardiomyopathy (HCM).
Kyung Eun Ha   +8 more
doaj   +2 more sources

7. Septal myectomy for hypertrophic obstructive cardiomyopathy in the young adults and children

open access: yesJournal of the Saudi Heart Association, 2015
Hypertrophic obstructive cardiomyopathy (HOCM) is one of the leading causes for heart failure in the young; few studies were published the results of surgical therapy in this age category.
Salah Eldien Altarabsheh   +3 more
doaj   +2 more sources

Successful Percutaneous Septal Alcohol Ablation After Surgical Myectomy

open access: yesBiomolecules & Biomedicine, 2010
Hypertrophic obstructive cardiomyopathy (HOCM) is a primary, usually familial and genetically fixed myocardial hypertrophy, with dynamic left ventricular outflow tract obstruction.
Mehmed Kulić   +6 more
doaj   +2 more sources

Role of Septal Myectomy in Pediatric Hypertrophic Cardiomyopathy [PDF]

open access: yesKardiyovasküler Tıp E Dergisi/E Journal of Cardiovascular Medicine
Hypertrophic cardiomyopathy is a prevalent cause of sudden cardiac death among young people. This distinctive genetic condition can manifest at any age from infancy to adulthood.
Sameh M. Said
doaj   +2 more sources

Analysis of electrocardiographic signs in hypertrophic cardiomyopathy before and after septal myectomy. New criterion for proximal left bundle branch block [PDF]

open access: yesРоссийский кардиологический журнал, 2022
Aim. To analyze 20 electrocardiographic (ECG) signs of left bundle branch block (LBBB) before and after septal myectomy in patients with hypertrophic cardio myopathy (HCM) and develop a criterion for proximal LBBB based on the selected signs.Material and 
L. M. Malishevsky   +8 more
doaj   +2 more sources

Endocardial septal ablation for hypertrophic obstructive cardiomyopathy

open access: yesTürk Kardiyoloji Derneği Arşivi, 2017
Summary– Septal reduction therapy (SRT) is the accepted therapeutic option for symptomatic hypertrophic obstructive cardiomyopathy (HOCM). At this time, surgical septal myectomy is the gold standard method, but alcohol septal ablation is an acceptable ...
Tolga Aksu   +4 more
doaj   +2 more sources

Precision myectomy: Real-time on-pump intracardiac echocardiography for resection in patients with thin septaCentral MessagePerspective

open access: yesJTCVS Techniques
Objective: During septal myectomy, once the heart is arrested and drained of blood on cardiopulmonary bypass, transesophageal echocardiography can no longer assess septal thickness.
Katherine G. Phillips, MD   +9 more
doaj   +2 more sources

Long-term outcomes of surgery for obstructive hypertrophic cardiomyopathy in a pediatric cohortCentral MessagePerspective

open access: yesJTCVS Open, 2023
Background: Septal reduction therapy via septal myectomy or a modified Konno procedure is the mainstay of therapy for drug-refractory obstructive hypertrophic cardiomyopathy (HCM), although outcomes data on septal myectomy in pediatric patients are ...
Stephanie N. Nguyen, MD   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy